Search

Wei Sun Phones & Addresses

  • College Park, MD
  • Greenbelt, MD

Specialities

Real Estate • Litigation • Commercial

Professional Records

License Records

Wei Sun

License #:
0225210071
Category:
Real Estate Individual

Wei Sun

License #:
30688 - Expired
Issued Date:
Nov 12, 2013
Expiration Date:
Jun 30, 2015
Type:
Certified Public Accountant

Lawyers & Attorneys

Wei Sun Photo 1

Wei Sun - Lawyer

View page
Licenses:
New York - Due to reregister within 30 days of birthday 1991
Education:
Columbia University School of Law
Wei Sun Photo 2

Wei Sun - Lawyer

View page
Address:
Shanghai Young-Ben Law Firm
(216) 148-4900 (Office)
Licenses:
New York - Currently registered 2012
Education:
Duke Law School
Wei Sun Photo 3

Wei Sun - Lawyer

View page
Specialties:
Real Estate
Litigation
Commercial
ISLN:
1000601356
Admitted:
2008

Medicine Doctors

Wei Sun Photo 4

Wei Y. Sun

View page
Specialties:
Nephrology
Work:
Chinatown Kidney Care
139 Ctr St STE 703, New York, NY 10013
(212) 966-0808 (phone), (212) 966-0880 (fax)
Education:
Medical School
Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71)
Graduated: 1988
Procedures:
Dialysis Procedures
Conditions:
Kidney Cancer
Acute Renal Failure
Chronic Renal Disease
Nephrotic Syndrome
Languages:
Chinese
English
Description:
Dr. Sun graduated from the Sun Yat Sen Univ of Med Sci, Guangzhou, China (242 21 Pr 1/71) in 1988. He works in New York, NY and specializes in Nephrology. Dr. Sun is affiliated with Mount Sinai Beth Israel Brooklyn Medical Center.
Wei Sun Photo 5

Wei W. Sun

View page
Specialties:
Anatomic Pathology & Clinical Pathology, Cytopathology
Work:
Pathology Associates
550 1 Ave STE 7N, New York, NY 10016
(212) 263-5475 (phone), (212) 263-5509 (fax)
Education:
Medical School
Shantou Univ Med Coll, Shantou, Guangdong, China
Graduated: 1982
Languages:
English
Description:
Dr. Sun graduated from the Shantou Univ Med Coll, Shantou, Guangdong, China in 1982. She works in New York, NY and specializes in Anatomic Pathology & Clinical Pathology and Cytopathology. Dr. Sun is affiliated with NYU Langone Medical Center.
Wei Sun Photo 6

Wei M. Sun

View page
Description:
Dr. Sun graduated from the Shanghai Med Univ, Shanghai First Med Univ, Shanghai, China in 1983. He works in Elgin, IL and 1 other location and specializes in Gastroenterology. Dr. Sun is affiliated with Advocate Sherman Hospital, Presence Saint Joseph Hospital and Presence Saint Joseph Medical Center.

Resumes

Resumes

Wei Sun Photo 7

Wei Sun Fairfax, VA

View page
Work:
Language and Foreign Studies, American University

Jun 2011 to 2000
Adjunct Faculty

Speech Communication, Montgomery College

2011 to 2000
Adjunct Professor

Communication and Culture Consulting, LLC

2010 to 2000
Principal Consultant

Howard University

2007 to 2000
Doctoral Student Dissertation Outside Examiner

Technical panel review for Lindberg Foundation

2004 to 2000

Zhunbei, Empowerment

2010 to 2010
Director

Graduate Committee

Sep 2008 to 2010
Student Services, Bowie State University

University Committee, Bowie State University

2007 to 2010

Lambda Pi Eta, National Communication

2006 to 2010
Faculty Advisor

Information Technology Committee

2005 to 2010
Departmental Web Manager

Communication Majors

Sep 2004 to 2010
Undergraduate Advisor

Information Technology Committee

2004 to 2010

Accreditation Committee

Sep 2008 to 2009

Information Technology Committee

May 2007 to 2009
Secretary

Beijing Institute of Graphic Communication

Jun 2008 to Aug 2008

Cross-cultural Crisis Communication Training Seminar for Jinan Science Association

Jun 2005 to Jun 2008
Guest Lectured to Faculty of Jinan University on American High Education

Communication Majors

2008 to 2008
Submitted and Chair

Information Technology Committee

2006 to 2008

Graduate Forum
Ocean City, MD
2005 to 2008

Open House Session

Sep 2005 to Mar 2007

Cross-cultural Crisis Communication Training Seminar for Jinan Science Association

2007 to 2007
Editorial Board member

Information Technology Committee

Mar 2006 to 2007

Information Technology Committee

2006 to 2007
Student Appealing Committee, Chair, Spring

Grant Committee

Sep 2004 to 2006

Library Committee

Sep 2004 to 2006

Conference programs for African American Division

2005 to 2005

Conference programs for African American Division

2005 to 2005
Chair

Association for Chinese Communication Studies

2004 to 2005
Newsletter Editor

Bowie State University

2004 to 2004
Assistant Professor, Department of Communications

Communication Majors

Mar 2003 to 2004
Undergraduate Student Advisor

Bloomsburg University

2003 to 2004

Faculty Search and Screen Committee
Sep 2002 to 2004

Bloomsburg University

2002 to 2004
Assistant Professor

Howard University

Jun 2001 to Jun 2003
Chinese Language Instructor

The Howard Journal of Communications

2002 to 2003
Chair for One ECA

The Howard Journal of Communications

1998 to 2002
Graduate Assistant

Association for Chinese Communication Studies (ACCS)

2000 to 2001
Chair of Student Affairs

Speech Communication Department, Edinboro University

1996 to 1997
Graduate Assistant

Jinan University
Jinan, CN
1992 to 1995
Director of Student Affairs

Jinan University
Jinan, CN
1988 to 1995
Assistant Professor and Lecturer

Chinese Department

1988 to 1995
Undergraduate Student Advisor

Education:
Howard University
Washington, DC
May 2002
Ph. D. in Communication and Culture

Edinboro University of Pennsylvania
Dec 1997
M.A. in Speech Communication

Beijing Normal University
1989
B. A. in Chinese Language and Literature

Qufu Normal University
1985

Wei Sun Photo 8

Wei Sun State College, PA

View page
Work:
Pennsylvania State University

2009 to 2000
Research Assistant

Pennsylvania State University

2012 to 2012
Fixed Income Research Project

Pennsylvania State University

2012 to 2012
Statistical Arbitrage Project

Deutsche Bank AG
Hong Kong, Hong Kong Island
2012 to 2012
Global Markets Summer Associate Internship

Pennsylvania State University

2011 to 2011
Data Mining Projects

Pennsylvania State University

2010 to 2011
Graduate Statistical Consulting

Food and Drug Administration
Silver Spring, MD
2010 to 2010
Summer Research Internship

HSBC Markets (Asia) Limited, Global Banking Advisory
Hong Kong, Hong Kong Island
2007 to 2007
Summer Internship

Education:
Peking University
2003 to 2007
BS in Mathematics

Pennsylvania State University
Ph.D. in Statistics

University graduate
Master

Skills:
Machine Learning: SVM, HMM, K-NN, Neutral Network, Boosting, Random Forest Computing: C++, R, MATLAB, SQL, Java, Excel VBA, Linux/Unix, Latex
Wei Sun Photo 9

Wei Sun Gaithersburg, MD

View page
Work:
Department of Biochemistry, Department of Bacterial and Rickettsial Disease, Walter Reed Army Institute of Research
Silver Spring, MD
Nov 2001 to Oct 2011
Principle Investigator / In vivo Specialist

The Division of Cardiovascular Medicine, University of Iowa Caver College of Medicine
Iowa City, IA
1998 to Nov 2001
Post Doctoral Fellow

The Department of Biology, University of Iowa
Iowa City, IA
Mar 1996 to Oct 1997
Post Doctoral Fellow

Department of Physiology and Pharmacology, University of Strathclyde
Glasgow, KY
1991 to 1996
PhD Candidate

Education:
University of Strathclyde
Glasgow
1991 to 1996
PhD in Physiology and Pharmacology

Peking University Health Science Center
Doctor of Medicine in Medicine

Wei Sun Photo 10

Wei Sun Fairfax, VA

View page
Work:
George Mason University

Jun 2009 to 2000
Research Assistant Professor

Dept. of Enterprise Optimization, United Airlines

Dec 2007 to Sep 2009
Senior Analyst

Typical Project
Education:
Department of Systems Engineering & Operations Research, George Mason Univeristy
Fairfax, VA
2003 to 2007
Ph.D. in Information Technology

Department of Systems Engineering & Operations Research, George Mason University
Fairfax, VA
2001 to 2003
Master of Science in Operations Research

Skills:
MATLAB, SAS, C/C++, ORCHESTRATE, NETICA

Business Records

Name / Title
Company / Classification
Phones & Addresses
Wei Sun
Manager
Aparna Biosciences Corporation
Biotech Research
12111 Parklawn Dr, Rockville, MD 20852
(301) 770-2101

Publications

Isbn (Books And Publications)

Minority Invisibility: An Asian American Experience

View page
Author

Wei Sun

ISBN #

0761837809

Tai Chi Ch'Uan: The Gentle Workout for Mind & Body

View page
Author

Wei Yue Sun

ISBN #

0806913665

New-Style Tai Chi Ch'Uan: The Offical Chinese System

View page
Author

Wei Yue Sun

ISBN #

0806997036

Us Patents

Large-Scale Production Of Human Serum Butyrylcholinesterase As A Bioscavenger

View page
US Patent:
7754461, Jul 13, 2010
Filed:
Apr 10, 2007
Appl. No.:
11/733246
Inventors:
Bhupendra P. Doctor - Potomac MD, US
Ashima Saxena - Fairfax VA, US
Wei Sun - Gaithersburg MD, US
Chunyuan Luo - North Potomac MD, US
Prasanthi Tipparaju - Rockville MD, US
Irwin Koplovitz - Bel Air MD, US
David E. Lenz - Belcamp MD, US
Michelle C. Ross - Edgewood MD, US
Assignee:
The United States of America as represented by the Secretary of the Army - Washington DC
International Classification:
C12N 9/16
C12N 9/14
C12N 9/00
A61K 38/46
US Classification:
435196, 435183, 435195, 424 946
Abstract:
Disclosed herein are methods for the large-scale preparation of human butyrylcholinesterase (HuBChE) preparations from Cohn Fraction IV-4. As disclosed, the methods provide HuBChE preparations that are about 99% or more pure with recovery yields of about 60%. Also disclosed are the pharmacokinetics, safety and toxicity, stability and efficacy of the HuBChE preparations.

Large-Scale Production Of Human Serum Butyrylcholinesterase As A Bioscavenger

View page
US Patent:
20060194301, Aug 31, 2006
Filed:
Oct 6, 2005
Appl. No.:
11/244173
Inventors:
Bhupendra Doctor - Potomac MD, US
Ashima Saxena - Fairfax VA, US
Wei Sun - Gaithersburg MD, US
Chunyuan Luo - North Potomac MD, US
Prasanthi Tipparaju - Rockville MD, US
Irwin Koplovitz - Bel Air MD, US
David Lenz - Belcamp MD, US
Michelle Ross - Edgewood MD, US
International Classification:
C12N 9/00
C12N 9/16
US Classification:
435196000, 435183000
Abstract:
Disclosed herein are methods for the large-scale preparation of human butyrylcholinesterase (HuBChE) preparations from Cohn Fraction IV-4. As disclosed, the methods provide HuBChE preparations that are about 99% or more pure with recovery yields of about 60%. Also disclosed are the pharmacokinetics, safety and toxicity, stability and efficacy of the HuBChE preparations.

Compounds And Method For Blocking Transmission Of Malarial Parasite

View page
US Patent:
20210246137, Aug 12, 2021
Filed:
Apr 22, 2021
Appl. No.:
17/237351
Inventors:
- Bethesda MD, US
- Chicago IL, US
Wei Sun - Germantown MD, US
Xiuli Huang - Potomac MD, US
Paresma R. Patel - Rockville MD, US
Wei Zheng - Potomac MD, US
Xiao Lu - Rockville MD, US
Philip E. Sanderson - Bethesda MD, US
Myunghoon Kim - Olympia WA, US
Meghan J. Orr - Nashville IL, US
Gregory J. Tawa - Doylestown PA, US
Kim C. Williamson - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
Loyola University of Chicago - Chicago IL
International Classification:
C07D 471/04
A61P 33/06
C07D 487/04
C07D 487/08
C07D 519/00
Abstract:
Disclosed are compounds of formula (I) and formula (II):wherein R, R, A, and B are as defined herein. Also disclosed is a method of blocking transmission of a parasite and a method of treating or preventing malaria comprising administering to an animal an effective amount of a first compound of formula (I) or (II) either alone or in combination with a second compound selected from elesclomol, NSC174938, NVP-AUY922, Maduramicin, Narasin, Alvespimycin, Omacetaxine, Thiram, Zinc pyrithione, Phanquinone, Bortezomib, Salinomycin sodium, Monensin sodium, Dipyrithione, Dicyclopentamethylene-thiuram disulfide, YM155, Withaferin A, Adriamycin, Romidepsin, AZD-1152-HQPA, CAY10581, Plicamycin, CUDC-101, Auranofin, Trametinib, GSK-458, Afatinib, and Panobinostat.

Combination Therapy For Treating Cancer

View page
US Patent:
20200031920, Jan 30, 2020
Filed:
Apr 4, 2018
Appl. No.:
16/500959
Inventors:
- Washington DC, US
- Bethesda MD, US
Wei ZHENG - Potomac MD, US
Wei SUN - Germantown MD, US
International Classification:
C07K 16/24
C07K 16/28
A61K 31/5025
A61K 31/506
A61K 31/5377
A61K 31/4164
A61K 31/555
Abstract:
The present disclosure provides methods, pharmaceutical compositions, dosing regimens, and kits comprising a DNA damaging agent and an inhibitor of the Janus kinase 2-signal transducer and activator of transcription 5 (JAK2-STAT5) pathway, including methods of inhibiting the JAK2-STAT5 pathway in a cell, methods of treating cancer in a subject, and methods of decreasing or reversing resistance to a DNA damaging agent in a subject.

Compounds And Method For Blocking Transmission Of Malarial Parasite

View page
US Patent:
20190315740, Oct 17, 2019
Filed:
Oct 13, 2017
Appl. No.:
16/341000
Inventors:
- Bethesda MD, US
- Chicago IL, US
Wei Sun - Germantown MD, US
Xiuli Huang - Potomac MD, US
Paresma R. Patel - Rockville MD, US
Wei Zheng - Potomac MD, US
Xiao Lu - Rockville MD, US
Philip E. Sanderson - Bethesda MD, US
Myunghoon Kim - Olympia WA, US
Meghan J. Orr - Chicago IL, US
Gregory J. Tawa - Rockville MD, US
Kim C. Williamson - Bethesda MD, US
Assignee:
The United States of America,as represented by the Secretary,Department of Health and Human Services - Bethesda MD
Loyola University of Chicago - Chicago IL
International Classification:
C07D 471/04
C07D 487/04
A61P 33/06
C07D 487/08
C07D 519/00
Abstract:
Disclosed are compounds of formula (I) and formula (II): (I) (II) wherein R, R, A, and B are as defined herein. Also disclosed is a method of blocking transmission of a parasite and a method of treating or preventing malaria comprising administering to an animal an effective amount of a first compound of formula (I) or (II) either alone or in combination with a second compound selected from elesclomol, NSC174938, NVP-AUY922, Maduramicin, Narasin, Alvespimycin, Omacetaxine, Thiram, Zinc pyrithione, Phanquinone, Bortezomib, Salinomycin sodium, Monensin sodium, Dipyrithione, Dicyclopentamethylene-thiuram disulfide, YM155, Withaferin A, Adriamycin, Romidepsin, AZD-1152-HQPA, CAY10581, Plicamycin, CUDC-101, Auranofin, Trametinib, GSK-458, Afatinib, and Panobinostat.

Method Of Blocking Transmission Of Malarial Parasite

View page
US Patent:
20160264570, Sep 15, 2016
Filed:
Nov 14, 2014
Appl. No.:
15/036355
Inventors:
- Bethesda MD, US
- Chicago IL, US
Kim C. Williamson - Bethesda MD, US
Wenwei Huang - Rockville MD, US
Wei Sun - Gaithersburg MD, US
Takeshi Tanaka - Hakodate, JP
Seameen Jean Dehdashti - Poolesville MD, US
Noel Terrence Southall - Potomac MD, US
Crystal Tobin Magle - Chicago IL, US
Xiuli Huang - Potomac MD, US
Paresma Rasiklal Patel - Rockville MD, US
Myunghoon Kim - Olympia WA, US
International Classification:
C07D 471/04
A61K 31/496
A61K 31/4745
A61K 31/5377
A61K 45/06
A61K 31/506
Abstract:
The invention provides a method of blocking transmission of a parasite and a method of treating or preventing malaria comprising administering to an animal an effective amount of a first compound of formula I: wherein A, B, R, R, R, and Rare described herein, either alone or in combination with a second compound selected from elesclomol, NSC 174938, NVP-AUY922, Maduramicin, Narasin, Alvespimycin, Omacetaxine, Thiram, Zinc pyrithione, Phanquinone, Bortezomib, Salinomycin sodium, Monensin sodium, Dipyrithione, Dicyclopentamethylene-thiuram disulfide, YM155, Withaferin A, Adriamycin, Romidepsin, AZD-1 152-HQPA, CAY10581, Plicamycin, CUDC-101, Auranofin, Trametinib, GSK-458, Afatinib, and Panobinostat.
Wei Sun from College Park, MD Get Report